These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7918392)

  • 1. Tissue-type plasminogen activator domain-deletion mutant BM 06.022: modular stability, inhibitor binding, and activation cleavage.
    Hu CK; Kohnert U; Wilhelm O; Fischer S; Llinás M
    Biochemistry; 1994 Oct; 33(39):11760-6. PubMed ID: 7918392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexation of the tissue plasminogen activator protease with benzamidine-type inhibitors: interference by the kringle 2 module.
    Hu CK; Kohnert U; Sturzebecher J; Fischer S; Llinas M
    Biochemistry; 1996 Mar; 35(10):3270-6. PubMed ID: 8605163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain structure and interactions of recombinant urokinase-type plasminogen activator.
    Novokhatny V; Medved L; Mazar A; Marcotte P; Henkin J; Ingham K
    J Biol Chem; 1992 Feb; 267(6):3878-85. PubMed ID: 1310986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR.
    Byeon IJ; Kelley RF; Mulkerrin MG; An SS; Llinás M
    Biochemistry; 1995 Mar; 34(9):2739-50. PubMed ID: 7893685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
    Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
    Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022.
    Kohnert U; Wozny M; Llinas M; Roos A; Fischer S
    Appl Biochem Biotechnol; 1995 Nov; 55(2):157-66. PubMed ID: 7495332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.
    Byeon IJ; Kelley RF; Llinás M
    Biochemistry; 1989 Nov; 28(24):9350-60. PubMed ID: 2558718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of tyrosine-76 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability and its omega-amino acid ligand binding site.
    De Serrano VS; Castellino FJ
    Biochemistry; 1994 Mar; 33(12):3509-14. PubMed ID: 8142348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfolding studies of the protease domain of urokinase-type plasminogen activator: the existence of partly folded states and stable subdomains.
    Nowak UK; Cooper A; Saunders D; Smith RA; Dobson CM
    Biochemistry; 1994 Mar; 33(10):2951-60. PubMed ID: 8130209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties.
    Chang Y; Zajicek J; Castellino FJ
    Biochemistry; 1997 Jun; 36(25):7652-63. PubMed ID: 9201906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the strictly conserved tryptophan-25 residue in the stabilization of the structure and in the ligand binding properties of the kringle 2 domain of tissue-type plasminogen activator.
    De Serrano VS; Castellino FJ
    Biochemistry; 1994 Feb; 33(6):1340-4. PubMed ID: 8312251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tryptophan-74 of the recombinant kringle 2 domain of tissue-type plasminogen activator in its omega-amino acid binding properties.
    De Serrano VS; Castellino FJ
    Biochemistry; 1992 Apr; 31(13):3326-35. PubMed ID: 1554717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain structure and domain-domain interactions of recombinant tissue plasminogen activator.
    Novokhatny VV; Ingham KC; Medved LV
    J Biol Chem; 1991 Jul; 266(20):12994-3002. PubMed ID: 1906462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
    Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
    Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2.
    Carroll VA; Nikitenko LL; Bicknell R; Harris AL
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):736-41. PubMed ID: 15692103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS
    Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of residue 65 substitutions on thermal stability of tissue plasminogen activator kringle-2 domain.
    Kelley RF; Cleary S
    Biochemistry; 1989 May; 28(9):4047-54. PubMed ID: 2502177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.
    De Serrano VS; Castellino FJ
    Biochemistry; 1993 Apr; 32(14):3540-8. PubMed ID: 8385482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug.
    Byeon IJ; Llinás M
    J Mol Biol; 1991 Dec; 222(4):1035-51. PubMed ID: 1762144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.